Index S&P 500
P/E 27.40
EPS (ttm) 5.44
Insider Own 0.82%
Shs Outstand 174.60M
Perf Week 0.42%
Market Cap 26.04B
Forward P/E 20.51
EPS next Y 7.27
Insider Trans -6.76%
Shs Float 173.12M
Perf Month -3.66%
Income 969.00M
PEG 6.31
EPS next Q 1.38
Inst Own 87.16%
Short Float 2.31%
Perf Quarter -4.19%
Sales 5.34B
P/S 4.87
EPS this Y -26.75%
Inst Trans -3.16%
Short Ratio 3.06
Perf Half Y 23.49%
Book/sh 27.54
P/B 5.42
EPS next Y 19.19%
ROA 11.07%
Short Interest 4.00M
Perf Year 4.64%
Cash/sh 10.01
P/C 14.90
EPS next 5Y 4.34%
ROE 21.02%
52W Range 118.57 - 172.72
Perf YTD -6.23%
Dividend Est. -
P/FCF 21.94
EPS past 5Y 46.88%
ROI 15.57%
52W High -13.63%
Beta 1.03
Dividend TTM -
Quick Ratio 1.34
Sales past 5Y 7.32%
Gross Margin 64.62%
52W Low 25.82%
ATR (14) 3.10
Dividend Ex-Date -
Current Ratio 1.93
EPS Y/Y TTM -15.05%
Oper. Margin 23.62%
RSI (14) 47.70
Volatility 1.75% 1.99%
Employees 14900
Debt/Eq 0.43
Sales Y/Y TTM -3.77%
Profit Margin 18.14%
Recom 2.09
Target Price 162.44
Option/Short Yes / Yes
LT Debt/Eq 0.29
EPS Q/Q -32.34%
Payout 0.00%
Rel Volume 0.44
Prev Close 146.99
Sales Surprise 0.88%
EPS Surprise 2.78%
Sales Q/Q -8.83%
Earnings Apr 30 AMC
Avg Volume 1.31M
Price 149.18
SMA20 -1.19%
SMA50 -2.15%
SMA200 2.66%
Trades
Volume 576,520
Change 1.49%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Downgrade
JP Morgan
Overweight → Neutral
$184 → $170
Sep-15-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$165
Sep-05-23 Upgrade
Goldman
Neutral → Buy
$146 → $164
Aug-18-23 Downgrade
Barclays
Overweight → Equal Weight
$204 → $144
Aug-14-23 Downgrade
BofA Securities
Neutral → Underperform
$163 → $148
Jun-30-23 Initiated
Citigroup
Buy
$200
Jan-11-23 Downgrade
Goldman
Buy → Neutral
$196 → $189
Jan-10-23 Upgrade
Barclays
Equal Weight → Overweight
$175 → $202
Nov-03-22 Initiated
Wells Fargo
Overweight
$200
Mar-11-22 Upgrade
Deutsche Bank
Hold → Buy
$176
Dec-08-21 Initiated
Morgan Stanley
Equal-Weight
$200
Nov-23-21 Reiterated
Jefferies
Buy
$190 → $220
Nov-23-21 Reiterated
Credit Suisse
Outperform
$175 → $210
Nov-23-21 Reiterated
Citigroup
Buy
$190 → $220
Jul-02-21 Downgrade
Barclays
Overweight → Equal Weight
$162
Jan-25-21 Downgrade
Deutsche Bank
Buy → Hold
$150
Nov-16-20 Initiated
Deutsche Bank
Buy
$129
Sep-16-20 Initiated
UBS
Buy
$133
Aug-13-20 Upgrade
Goldman
Neutral → Buy
$120
Aug-04-20 Initiated
Edward Jones
Buy
Show Previous Ratings
Apr-30-24 11:00AM
Apr-29-24 11:00AM
08:00AM
Apr-24-24 11:00AM
Apr-18-24 11:00AM
11:47AM
Loading…
Apr-04-24 11:47AM
Apr-03-24 11:00AM
Mar-29-24 06:47AM
Mar-28-24 08:05AM
03:50AM
03:21AM
03:16AM
Mar-27-24 05:44PM
04:23PM
04:19PM
04:16PM
Loading…
04:16PM
Mar-25-24 11:00AM
Mar-21-24 11:30AM
Mar-20-24 12:41PM
11:00AM
Mar-19-24 01:00PM
11:00AM
Mar-13-24 11:00AM
Mar-12-24 12:16PM
Mar-11-24 11:00AM
Mar-06-24 11:00AM
10:37AM
Mar-05-24 11:00AM
Mar-01-24 11:01AM
Feb-29-24 12:56PM
11:00AM
Loading…
11:00AM
Feb-28-24 11:00AM
01:30AM
Feb-27-24 11:00AM
08:51AM
Feb-26-24 03:17PM
11:00AM
Feb-25-24 11:00AM
Feb-23-24 12:21PM
08:00AM
Feb-22-24 11:00AM
Feb-21-24 01:00PM
12:12PM
11:00AM
09:50AM
09:43AM
08:41AM
(Thomson Reuters StreetEvents)
01:13AM
Feb-20-24 06:00PM
05:15PM
04:31PM
04:18PM
(Associated Press Finance)
04:05PM
Feb-19-24 12:10PM
11:37AM
Feb-16-24 11:00AM
09:14AM
Feb-15-24 11:00AM
Feb-14-24 09:15AM
Feb-13-24 11:00AM
10:00AM
09:12AM
Feb-12-24 11:00AM
Feb-08-24 07:27AM
Feb-01-24 11:00AM
Jan-31-24 11:00AM
08:39AM
Jan-30-24 11:00AM
11:00AM
09:45AM
08:00AM
Jan-29-24 01:00PM
11:00AM
Jan-25-24 11:00AM
Jan-24-24 11:00AM
09:00AM
Jan-22-24 07:00PM
Jan-18-24 06:30AM
Jan-16-24 11:00AM
Jan-10-24 04:05PM
Jan-09-24 12:55PM
11:00AM
Jan-03-24 11:30AM
Jan-02-24 11:00AM
Dec-29-23 07:01AM
Dec-20-23 11:30AM
Dec-19-23 09:04AM
Dec-18-23 07:25AM
Dec-16-23 01:22AM
Dec-15-23 11:00AM
10:06AM
Dec-14-23 06:39PM
Dec-13-23 11:00AM
06:52AM
Dec-12-23 11:00AM
Dec-10-23 05:05AM
Dec-05-23 11:00AM
Nov-30-23 04:10PM
04:05PM
11:18AM
Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization and secure operation of electronics systems to communications, networking and electronics industries. It operates through the following segments: Communications Solutions Group, and Electronic Industrial Solutions Group. The Communications Solutions Group segment serves customers spanning the worldwide commercial communications end market, which includes internet infrastructure, and the aerospace, defense and government end market. The Electronic Industrial Solutions Group segment offers test and measurement solutions across a broad set of electronic industrial end markets, focusing on high-growth applications in the automotive and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
NARAYANAN KAILASH SVP Mar 26 '24 Sale 152.88 4,300 657,384 29,156 Mar 28 04:17 PM Nersesian Ronald S. Director Dec 27 '23 Sale 159.82 29,672 4,742,179 296,619 Dec 28 04:04 PM Dougherty Neil EVP and CFO Dec 15 '23 Sale 159.35 14,686 2,340,214 106,793 Dec 18 05:36 PM NARAYANAN KAILASH SVP Dec 15 '23 Sale 159.16 1,006 160,117 33,456 Dec 18 05:36 PM Ee Huei Sin SVP Dec 14 '23 Sale 156.47 5,000 782,325 44,317 Dec 15 05:45 PM PAGE JOHN SVP Dec 13 '23 Sale 150.00 6,155 923,250 36,767 Dec 15 05:44 PM Li Jeffrey K SVP and Secretary Dec 13 '23 Sale 150.00 4,748 712,200 28,174 Dec 15 05:44 PM Gooi Soon Chai SVP Dec 12 '23 Sale 148.03 14,900 2,205,592 239,488 Dec 13 04:22 PM CULLEN JAMES Director Dec 11 '23 Sale 146.47 4,869 713,154 20,730 Dec 13 04:21 PM Dhanasekaran Satish President and CEO Dec 06 '23 Sale 140.00 11,138 1,559,320 105,139 Dec 08 04:13 PM Dhanasekaran Satish President and CEO Nov 27 '23 Sale 134.90 7,275 981,398 116,277 Nov 29 04:16 PM NARAYANAN KAILASH SVP Jun 13 '23 Sale 165.00 500 82,500 26,169 Jun 14 04:15 PM PAGE JOHN SVP Jun 12 '23 Sale 163.81 20,000 3,276,218 36,219 Jun 14 04:15 PM Gooi Soon Chai SVP May 30 '23 Sale 161.95 29,139 4,719,201 227,874 Jun 01 04:18 PM HAMADA RICHARD P Director May 23 '23 Sale 159.03 1,543 245,387 42,160 May 25 04:09 PM Stephens Kevin A Director May 19 '23 Buy 157.45 420 66,129 5,589 May 22 04:45 PM
Index S&P 500
P/E 39.37
EPS (ttm) 1.94
Insider Own 1.28%
Shs Outstand 241.71M
Perf Week 0.74%
Market Cap 17.97B
Forward P/E 17.26
EPS next Y 4.43
Insider Trans -3.94%
Shs Float 231.72M
Perf Month -0.96%
Income 466.50M
PEG 5.32
EPS next Q 1.02
Inst Own 98.34%
Short Float 1.95%
Perf Quarter 5.66%
Sales 3.96B
P/S 4.54
EPS this Y 2.53%
Inst Trans -9.74%
Short Ratio 2.66
Perf Half Y 14.77%
Book/sh 20.76
P/B 3.69
EPS next Y 9.19%
ROA 5.14%
Short Interest 4.52M
Perf Year -8.98%
Cash/sh 9.29
P/C 8.24
EPS next 5Y 7.40%
ROE 9.20%
52W Range 64.02 - 86.74
Perf YTD 7.12%
Dividend Est. -
P/FCF 18.93
EPS past 5Y -
ROI 6.33%
52W High -11.76%
Beta 1.02
Dividend TTM -
Quick Ratio 3.29
Sales past 5Y 7.03%
Gross Margin 54.30%
52W Low 19.56%
ATR (14) 1.51
Dividend Ex-Date -
Current Ratio 3.97
EPS Y/Y TTM -35.24%
Oper. Margin 21.72%
RSI (14) 51.68
Volatility 2.51% 1.82%
Employees 6990
Debt/Eq 0.53
Sales Y/Y TTM -2.37%
Profit Margin 11.78%
Recom 2.11
Target Price 85.86
Option/Short Yes / Yes
LT Debt/Eq 0.52
EPS Q/Q -18.23%
Payout 0.00%
Rel Volume 1.20
Prev Close 75.91
Sales Surprise 1.60%
EPS Surprise 5.34%
Sales Q/Q -0.85%
Earnings May 02 AMC
Avg Volume 1.70M
Price 76.54
SMA20 -0.01%
SMA50 0.61%
SMA200 4.45%
Trades
Volume 2,028,653
Change 0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Jul-06-21 Upgrade
Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade
Needham
Buy → Hold
Nov-05-20 Reiterated
Needham
Buy
$78 → $88
Jun-30-20 Upgrade
Cowen
Market Perform → Outperform
$64
Jun-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$62
Apr-30-20 Upgrade
SVB Leerink
Mkt Perform → Outperform
$62
Apr-30-20 Reiterated
Needham
Buy
$52 → $60
Apr-07-20 Upgrade
Wells Fargo
Equal Weight → Overweight
$48
Show Previous Ratings
Today 01:07AM
May-03-24 12:40PM
12:29PM
11:54AM
10:51AM
09:43AM
Loading…
09:43AM
07:17AM
(Thomson Reuters StreetEvents)
May-02-24 09:59PM
08:58PM
08:00PM
05:45PM
05:10PM
04:40PM
04:07PM
(Associated Press Finance)
04:01PM
06:27AM
Loading…
Apr-30-24 06:27AM
Apr-29-24 05:58PM
04:05PM
11:44AM
09:16AM
Apr-25-24 10:01AM
Apr-22-24 05:45PM
Apr-21-24 08:30AM
Apr-19-24 11:30AM
09:00AM
Apr-17-24 11:01AM
Apr-15-24 05:45PM
Apr-12-24 10:45AM
Apr-11-24 02:07PM
09:15AM
05:45PM
Loading…
Apr-08-24 05:45PM
09:00AM
Apr-03-24 12:10PM
09:54AM
Apr-02-24 05:45PM
08:08AM
Mar-28-24 07:24AM
Mar-27-24 09:00AM
Mar-25-24 05:45PM
Mar-19-24 12:53PM
(The Wall Street Journal)
Mar-18-24 05:45PM
Mar-15-24 07:00PM
09:00AM
Mar-12-24 05:45PM
Mar-06-24 11:15AM
Mar-05-24 08:10AM
Mar-04-24 09:00AM
Feb-28-24 01:16AM
Feb-27-24 03:44PM
03:30PM
08:00AM
Feb-26-24 04:15PM
Feb-21-24 09:00AM
Feb-18-24 01:26PM
Feb-06-24 10:43AM
Feb-05-24 03:31PM
01:43PM
10:40AM
09:00AM
Feb-03-24 12:08AM
Feb-02-24 12:52PM
11:08AM
07:05AM
(Thomson Reuters StreetEvents)
Feb-01-24 05:35PM
05:30PM
05:21PM
04:45PM
04:10PM
(Associated Press Finance)
04:01PM
Jan-31-24 11:17AM
Jan-30-24 07:29PM
Jan-29-24 09:16AM
Jan-25-24 11:00AM
(The Wall Street Journal)
10:00AM
Jan-22-24 05:45PM
Jan-20-24 03:19PM
Jan-19-24 09:00AM
Jan-18-24 11:30AM
Jan-17-24 12:10PM
12:07PM
Jan-16-24 05:45PM
08:30AM
Jan-11-24 08:08AM
Jan-09-24 05:45PM
Jan-08-24 09:00AM
Jan-07-24 04:00PM
Jan-04-24 08:33AM
Jan-02-24 05:45PM
08:08AM
Dec-28-23 04:28AM
Dec-27-23 05:45PM
09:00AM
Dec-20-23 05:45PM
Dec-18-23 07:39AM
Dec-14-23 05:45PM
05:05PM
Dec-11-23 06:55AM
Dec-07-23 03:37AM
Dec-05-23 09:00AM
Dec-03-23 05:25AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM GARRETT SCOTT T Director Dec 11 '23 Sale 68.71 10,000 687,116 47,039 Dec 13 04:07 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Option Exercise 26.21 47,711 1,250,505 1,286,799 Dec 01 04:04 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Sale 70.41 47,711 3,359,188 1,239,088 Dec 01 04:04 PM Mitchell Essex D Div. President, GYN Surgical Nov 21 '23 Sale 71.85 7,500 538,890 12,827 Nov 24 04:02 PM GARRETT SCOTT T Director Jun 15 '23 Sale 79.72 10,000 797,240 57,039 Jun 20 05:03 PM Mitchell Essex D Div. President, GYN Surgical May 05 '23 Sale 83.73 2,390 200,115 7,212 May 09 04:18 PM
Index RUT
P/E 38.30
EPS (ttm) 2.46
Insider Own 0.98%
Shs Outstand 50.45M
Perf Week 3.75%
Market Cap 4.79B
Forward P/E 21.44
EPS next Y 4.40
Insider Trans 0.00%
Shs Float 50.29M
Perf Month 11.20%
Income 126.57M
PEG 3.19
EPS next Q 0.89
Inst Own 100.98%
Short Float 4.45%
Perf Quarter 23.69%
Sales 1.27B
P/S 3.77
EPS this Y 30.66%
Inst Trans -0.61%
Short Ratio 4.59
Perf Half Y 9.27%
Book/sh 18.57
P/B 5.08
EPS next Y 11.21%
ROA 6.21%
Short Interest 2.24M
Perf Year 15.42%
Cash/sh 3.82
P/C 24.72
EPS next 5Y 12.00%
ROE 14.72%
52W Range 70.74 - 95.26
Perf YTD 10.40%
Dividend Est. -
P/FCF 37.57
EPS past 5Y 21.43%
ROI 7.03%
52W High -0.90%
Beta 0.40
Dividend TTM -
Quick Ratio 1.76
Sales past 5Y 5.50%
Gross Margin 51.78%
52W Low 33.45%
ATR (14) 2.14
Dividend Ex-Date -
Current Ratio 2.92
EPS Y/Y TTM 32.86%
Oper. Margin 15.76%
RSI (14) 76.15
Volatility 1.99% 2.37%
Employees 3034
Debt/Eq 0.92
Sales Y/Y TTM 12.48%
Profit Margin 9.97%
Recom 1.71
Target Price 105.83
Option/Short Yes / Yes
LT Debt/Eq 0.91
EPS Q/Q -5.58%
Payout 0.00%
Rel Volume 0.76
Prev Close 93.33
Sales Surprise 4.80%
EPS Surprise 10.46%
Sales Q/Q 10.14%
Earnings May 09 BMO
Avg Volume 487.44K
Price 94.40
SMA20 8.75%
SMA50 15.51%
SMA200 11.11%
Trades
Volume 368,663
Change 1.15%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-13-22 Initiated
Mizuho
Buy
$90
Jan-27-22 Downgrade
Needham
Buy → Hold
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$75 → $59
Aug-17-21 Resumed
Raymond James
Outperform
$75
Jun-17-21 Initiated
Citigroup
Buy
$75
May-14-21 Upgrade
CJS Securities
Market Perform → Market Outperform
Apr-20-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Apr-19-21 Downgrade
CJS Securities
Market Outperform → Market Perform
Feb-03-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$140
Jan-21-21 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-05-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$106
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Jan-10-20 Initiated
Needham
Buy
$138
Aug-07-19 Reiterated
Barrington Research
Outperform
$116 → $139
May-14-19 Upgrade
Raymond James
Mkt Perform → Outperform
$110
May-08-19 Reiterated
Barrington Research
Outperform
$112 → $116
Aug-09-18 Reiterated
Barrington Research
Outperform
$90 → $118
Feb-07-18 Reiterated
Barrington Research
Outperform
$57 → $71
Jan-02-18 Upgrade
Morgan Stanley
Equal-Weight → Overweight
Show Previous Ratings
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
06:30AM
Loading…
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
01:26PM
Loading…
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
(Thomson Reuters StreetEvents)
09:30AM
07:10AM
06:33AM
06:10AM
(Associated Press Finance)
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
04:05PM
Loading…
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
07:34AM
07:00AM
06:18AM
(Associated Press Finance)
06:00AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
09:40AM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
11:05AM
Oct-17-23 11:17AM
08:33AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
08:14AM
Oct-11-23 12:00PM
11:13AM
08:23AM
Oct-10-23 06:00AM
06:00AM
Oct-09-23 08:35AM
Oct-06-23 07:48AM
Oct-05-23 04:05PM
11:16AM
09:51AM
08:32AM
08:25AM
Oct-04-23 09:50AM
09:40AM
08:47AM
Oct-03-23 11:11AM
08:56AM
Sep-29-23 09:45AM
08:49AM
08:32AM
Sep-28-23 10:37AM
09:06AM
Sep-27-23 09:12AM
07:47AM
Sep-26-23 11:10AM
11:06AM
08:02AM
Sep-25-23 11:40AM
09:45AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Strong Stewart W President, Global Hospital Sep 12 '23 Sale 90.65 228 20,668 16,221 Sep 13 04:19 PM Lingamneni Anila EVP, Chief Technology Officer Sep 11 '23 Sale 90.00 2,305 207,450 14,495 Sep 13 04:20 PM Dockendorff Charles J Director Sep 05 '23 Sale 87.68 10,215 895,651 2,226 Sep 07 04:23 PM Llorens Josep EVP, Global Manufacturing Jul 18 '23 Option Exercise 57.10 4,928 281,390 23,391 Jul 20 04:17 PM Llorens Josep EVP, Global Manufacturing Jul 18 '23 Sale 90.00 4,928 443,520 18,463 Jul 20 04:17 PM Simon, Christopher President & CEO Jun 29 '23 Option Exercise 28.61 196,746 5,629,887 414,113 Jun 30 04:17 PM Strong Stewart W President, Global Hospital Jun 07 '23 Option Exercise 56.93 6,893 392,419 24,040 Jun 09 04:16 PM Strong Stewart W President, Global Hospital Jun 07 '23 Sale 88.04 2,538 223,446 16,449 Jun 09 04:16 PM Lingamneni Anila EVP, Chief Technology Officer May 30 '23 Sale 83.33 2,304 191,992 16,800 Jun 01 04:19 PM
Index S&P 500
P/E 60.87
EPS (ttm) 1.20
Insider Own 0.45%
Shs Outstand 1.47B
Perf Week -0.44%
Market Cap 107.08B
Forward P/E 27.63
EPS next Y 2.64
Insider Trans -5.73%
Shs Float 1.46B
Perf Month 7.53%
Income 1.76B
PEG 4.91
EPS next Q 0.58
Inst Own 93.85%
Short Float 0.90%
Perf Quarter 13.17%
Sales 14.71B
P/S 7.28
EPS this Y 13.39%
Inst Trans 0.92%
Short Ratio 2.06
Perf Half Y 41.02%
Book/sh 13.56
P/B 5.37
EPS next Y 13.44%
ROA 5.09%
Short Interest 13.16M
Perf Year 38.26%
Cash/sh 1.65
P/C 44.21
EPS next 5Y 12.40%
ROE 9.38%
52W Range 48.35 - 74.39
Perf YTD 26.02%
Dividend Est. -
P/FCF 63.06
EPS past 5Y -2.05%
ROI 5.91%
52W High -2.07%
Beta 0.81
Dividend TTM -
Quick Ratio 1.14
Sales past 5Y 8.10%
Gross Margin 62.14%
52W Low 50.67%
ATR (14) 1.35
Dividend Ex-Date -
Current Ratio 1.66
EPS Y/Y TTM 104.30%
Oper. Margin 15.71%
RSI (14) 68.17
Volatility 1.99% 1.69%
Employees 48000
Debt/Eq 0.55
Sales Y/Y TTM 12.74%
Profit Margin 12.00%
Recom 1.41
Target Price 81.70
Option/Short Yes / Yes
LT Debt/Eq 0.50
EPS Q/Q 61.01%
Payout 0.00%
Rel Volume 1.13
Prev Close 72.03
Sales Surprise 4.67%
EPS Surprise 9.03%
Sales Q/Q 13.78%
Earnings Apr 24 BMO
Avg Volume 6.40M
Price 72.85
SMA20 4.47%
SMA50 6.71%
SMA200 24.80%
Trades
Volume 7,210,422
Change 1.14%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-01-24 Upgrade
Mizuho
Neutral → Buy
$65 → $80
Jul-19-23 Initiated
Robert W. Baird
Outperform
$59
Jun-30-23 Initiated
CL King
Buy
$64
May-30-23 Resumed
Morgan Stanley
Overweight
$58
Mar-29-23 Initiated
UBS
Buy
$57
Dec-22-22 Initiated
Mizuho
Neutral
$52
Dec-20-22 Resumed
Citigroup
Buy
$54
Oct-18-22 Initiated
Barclays
Overweight
$49
Oct-12-22 Initiated
Jefferies
Buy
$50
Jul-06-22 Initiated
Wolfe Research
Outperform
$43
May-27-22 Upgrade
Needham
Hold → Buy
$48
Apr-13-22 Resumed
Truist
Buy
$52
Mar-02-22 Resumed
BofA Securities
Buy
$55
Dec-10-21 Initiated
RBC Capital Mkts
Outperform
$51
May-26-21 Downgrade
Needham
Buy → Hold
May-25-21 Initiated
Barclays
Overweight
$51
Apr-15-21 Initiated
Atlantic Equities
Overweight
$52
Sep-17-20 Initiated
Truist
Buy
$47
Sep-11-20 Initiated
Wolfe Research
Peer Perform
$46
Apr-22-20 Downgrade
SVB Leerink
Outperform → Mkt Perform
$40
Show Previous Ratings
May-03-24 01:06AM
May-02-24 04:53PM
07:05AM
May-01-24 08:00AM
Apr-30-24 02:29PM
04:22PM
Loading…
Apr-29-24 04:22PM
09:40AM
Apr-26-24 11:32AM
09:50AM
08:20AM
Apr-25-24 11:34AM
10:53AM
10:25AM
10:21AM
09:45AM
08:35AM
Loading…
08:35AM
08:19AM
07:53AM
03:01AM
Apr-24-24 11:21PM
(Thomson Reuters StreetEvents) +5.68%
04:19PM
(Investor's Business Daily)
02:42PM
01:38PM
01:11PM
12:40PM
12:04PM
11:54AM
11:33AM
11:16AM
10:00AM
07:51AM
Loading…
07:51AM
07:40AM
07:20AM
07:11AM
(Investor's Business Daily)
06:53AM
06:39AM
(Associated Press Finance)
06:35AM
06:30AM
Apr-23-24 06:14AM
Apr-19-24 09:15AM
Apr-18-24 12:02PM
05:57AM
Apr-17-24 03:37PM
02:38PM
Apr-16-24 10:44AM
04:13AM
Apr-13-24 12:18PM
Apr-10-24 09:30AM
Apr-08-24 12:00AM
Apr-04-24 05:16PM
07:45AM
07:31AM
06:03AM
Apr-01-24 08:00AM
Mar-28-24 08:03AM
Mar-25-24 09:30PM
Mar-24-24 09:35AM
Mar-22-24 04:01PM
01:41AM
Mar-18-24 01:22PM
09:28AM
Mar-15-24 06:00AM
Mar-13-24 02:17PM
Mar-07-24 05:00AM
Mar-06-24 11:48AM
Mar-04-24 11:27AM
Mar-01-24 11:30AM
09:50AM
07:21AM
07:07AM
06:55AM
06:23AM
Feb-29-24 06:00AM
Feb-28-24 05:52PM
06:08AM
Feb-27-24 04:15PM
09:15AM
02:03AM
Feb-22-24 09:27PM
Feb-21-24 11:54AM
09:04AM
12:08AM
Feb-20-24 11:25AM
Feb-18-24 01:26PM
Feb-17-24 01:29PM
Feb-16-24 12:56PM
Feb-14-24 08:15AM
Feb-08-24 10:34AM
Feb-07-24 09:28AM
08:45AM
Feb-06-24 10:41AM
Feb-05-24 08:00AM
Feb-02-24 08:15AM
08:09AM
Feb-01-24 09:14AM
01:55AM
(Thomson Reuters StreetEvents)
Jan-31-24 07:40PM
04:07PM
(Investor's Business Daily)
11:55AM
11:02AM
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sorenson John Bradley EVP, Global Operations May 01 '24 Option Exercise 17.26 17,587 303,552 68,225 May 02 04:46 PM Carruthers Wendy EVP, Human Resources May 01 '24 Option Exercise 19.31 4,263 82,306 55,331 May 02 04:42 PM Sorenson John Bradley EVP, Global Operations May 01 '24 Sale 71.50 17,587 1,257,488 50,638 May 02 04:46 PM Carruthers Wendy EVP, Human Resources May 01 '24 Sale 71.47 6,983 499,075 48,348 May 02 04:42 PM LUDWIG EDWARD J Director Apr 26 '24 Option Exercise 17.37 9,818 170,539 51,192 Apr 29 04:12 PM LUDWIG EDWARD J Director Apr 26 '24 Sale 73.29 9,818 719,562 41,374 Apr 29 04:12 PM Sorenson John Bradley EVP, Global Operations Apr 01 '24 Option Exercise 16.31 16,351 266,685 66,989 Apr 02 06:57 PM Carruthers Wendy EVP, Human Resources Apr 01 '24 Option Exercise 19.31 4,263 82,306 58,051 Apr 02 06:57 PM Sorenson John Bradley EVP, Global Operations Apr 01 '24 Sale 69.30 16,351 1,133,069 50,638 Apr 02 06:57 PM Carruthers Wendy EVP, Human Resources Apr 01 '24 Sale 68.42 6,983 477,777 51,068 Apr 02 06:57 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Mar 18 '24 Sale 66.45 14,506 963,930 58,098 Mar 19 04:41 PM Carruthers Wendy EVP, Human Resources Mar 01 '24 Option Exercise 19.31 4,263 82,306 60,771 Mar 04 06:50 PM Carruthers Wendy EVP, Human Resources Mar 01 '24 Sale 66.35 6,983 463,322 53,788 Mar 04 06:50 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 26 '24 Option Exercise 21.40 4,185 89,542 38,272 Feb 27 04:19 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 26 '24 Sale 67.07 9,335 626,098 28,937 Feb 27 04:19 PM Carruthers Wendy EVP, Human Resources Feb 23 '24 Option Exercise 19.31 4,263 82,306 63,491 Feb 26 04:13 PM Carruthers Wendy EVP, Human Resources Feb 23 '24 Sale 66.89 6,983 467,093 56,508 Feb 26 04:13 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 21 '24 Sale 66.35 4,960 329,096 72,604 Feb 22 04:19 PM Brennan Daniel J. EVP and CFO Feb 20 '24 Option Exercise 13.08 13,662 178,699 285,204 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 20 '24 Sale 65.86 13,662 899,779 271,542 Feb 20 09:03 PM Sorenson John Bradley EVP, Global Operations Feb 18 '24 Option Exercise 0.00 1,186 0 51,179 Feb 20 09:05 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 18 '24 Option Exercise 0.00 2,002 0 31,204 Feb 20 09:05 PM Brown Vance R SVP, GC and Corp. Secretary Feb 18 '24 Option Exercise 0.00 741 0 32,544 Feb 20 09:03 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 18 '24 Option Exercise 0.00 3,706 0 194,696 Feb 20 09:03 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 18 '24 Option Exercise 0.00 2,372 0 35,139 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 18 '24 Option Exercise 0.00 3,706 0 273,186 Feb 20 09:03 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 18 '24 Option Exercise 0.00 2,817 0 78,849 Feb 20 09:04 PM Monson Jonathan SVP, Global Controller and CAO Feb 18 '24 Option Exercise 0.00 638 0 38,240 Feb 20 09:04 PM Mahoney Michael F Chairman, President & CEO Feb 18 '24 Option Exercise 0.00 16,307 0 1,681,111 Feb 20 09:03 PM Carruthers Wendy EVP, Human Resources Feb 18 '24 Option Exercise 0.00 1,853 0 63,100 Feb 20 09:03 PM Carruthers Wendy EVP, Human Resources Feb 17 '24 Option Exercise 0.00 2,250 0 62,245 Feb 20 09:03 PM Mahoney Michael F Chairman, President & CEO Feb 17 '24 Option Exercise 0.00 18,333 0 1,672,935 Feb 20 09:03 PM Monson Jonathan SVP, Global Controller and CAO Feb 17 '24 Option Exercise 0.00 1,000 0 38,006 Feb 20 09:04 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 17 '24 Option Exercise 0.00 3,333 0 77,552 Feb 20 09:04 PM Brennan Daniel J. EVP and CFO Feb 17 '24 Option Exercise 0.00 4,583 0 271,513 Feb 20 09:03 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 17 '24 Option Exercise 0.00 2,833 0 34,024 Feb 20 09:03 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 17 '24 Option Exercise 0.00 4,167 0 193,047 Feb 20 09:03 PM Brown Vance R SVP, GC and Corp. Secretary Feb 17 '24 Option Exercise 0.00 1,000 0 32,097 Feb 20 09:03 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 17 '24 Option Exercise 0.00 2,500 0 30,650 Feb 20 09:05 PM Sorenson John Bradley EVP, Global Operations Feb 17 '24 Option Exercise 0.00 1,500 0 50,678 Feb 20 09:05 PM Sorenson John Bradley EVP, Global Operations Feb 16 '24 Option Exercise 0.00 1,273 0 49,759 Feb 20 09:05 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 16 '24 Option Exercise 0.00 2,263 0 29,461 Feb 20 09:05 PM Brown Vance R SVP, GC and Corp. Secretary Feb 16 '24 Option Exercise 0.00 1,838 0 31,637 Feb 20 09:03 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 16 '24 Option Exercise 0.00 3,960 0 190,686 Feb 20 09:03 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 16 '24 Option Exercise 0.00 2,546 0 32,321 Feb 20 09:03 PM Brennan Daniel J. EVP and CFO Feb 16 '24 Option Exercise 0.00 4,243 0 268,812 Feb 20 09:03 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 16 '24 Option Exercise 0.00 2,970 0 75,574 Feb 20 09:04 PM Monson Jonathan SVP, Global Controller and CAO Feb 16 '24 Option Exercise 0.00 990 0 37,433 Feb 20 09:04 PM Mahoney Michael F Chairman, President & CEO Feb 16 '24 Option Exercise 0.00 16,265 0 1,661,816 Feb 20 09:03 PM Carruthers Wendy EVP, Human Resources Feb 16 '24 Option Exercise 0.00 2,051 0 60,905 Feb 20 09:03 PM Monson Jonathan SVP, Global Controller and CAO Feb 14 '24 Option Exercise 0.00 1,057 0 36,931 Feb 16 04:22 PM Sorenson John Bradley EVP, Global Operations Feb 14 '24 Option Exercise 0.00 2,115 0 49,451 Feb 16 04:23 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Feb 14 '24 Option Exercise 0.00 2,379 0 28,576 Feb 16 04:23 PM Brennan Daniel J. EVP and CFO Feb 14 '24 Option Exercise 0.00 4,362 0 266,504 Feb 16 04:21 PM Brown Vance R SVP, GC and Corp. Secretary Feb 14 '24 Option Exercise 0.00 1,850 0 30,428 Feb 16 04:21 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 14 '24 Option Exercise 0.00 3,172 0 31,183 Feb 16 04:21 PM Carruthers Wendy EVP, Human Resources Feb 14 '24 Option Exercise 0.00 2,115 0 59,793 Feb 16 04:21 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 14 '24 Option Exercise 0.00 4,362 0 188,716 Feb 16 04:21 PM Mahoney Michael F Chairman, President & CEO Feb 14 '24 Option Exercise 0.00 16,523 0 1,652,879 Feb 16 04:22 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Feb 14 '24 Option Exercise 0.00 2,776 0 73,870 Feb 16 04:22 PM LUDWIG EDWARD J Director Feb 13 '24 Option Exercise 17.37 7,000 121,590 48,374 Feb 14 04:23 PM LUDWIG EDWARD J Director Feb 13 '24 Sale 65.03 7,000 455,223 41,374 Feb 14 04:23 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Jan 12 '24 Sale 60.00 11,660 699,600 173,472 Jan 16 04:39 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 09 '24 Option Exercise 16.31 15,172 247,455 71,760 Jan 10 05:44 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 09 '24 Sale 59.25 15,172 898,941 56,588 Jan 10 05:44 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 04 '24 Option Exercise 16.31 15,000 244,650 71,588 Jan 05 04:53 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 04 '24 Sale 58.40 15,000 876,002 56,588 Jan 05 04:53 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 03 '24 Sale 57.82 11,931 689,862 56,588 Jan 04 04:15 PM Mahoney Michael F Chairman, President & CEO Jan 01 '24 Option Exercise 0.00 95,919 0 1,594,841 Jan 02 08:31 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Jan 01 '24 Option Exercise 0.00 17,439 0 74,027 Jan 02 08:31 PM Sorenson John Bradley EVP, Global Operations Jan 01 '24 Option Exercise 0.00 7,848 0 44,537 Jan 02 08:31 PM Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr Jan 01 '24 Option Exercise 0.00 13,080 0 25,349 Jan 02 08:31 PM Brennan Daniel J. EVP and CFO Jan 01 '24 Option Exercise 0.00 23,979 0 249,937 Jan 02 08:30 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Jan 01 '24 Option Exercise 0.00 14,823 0 21,800 Jan 02 08:30 PM Carruthers Wendy EVP, Human Resources Jan 01 '24 Option Exercise 0.00 11,772 0 53,041 Jan 02 08:30 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Jan 01 '24 Option Exercise 0.00 21,799 0 196,040 Jan 02 08:30 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Dec 29 '23 Option Exercise 16.31 58,189 949,063 256,181 Jan 02 08:30 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Dec 29 '23 Sale 57.50 81,940 4,711,550 174,241 Jan 02 08:30 PM Carruthers Wendy EVP, Human Resources Dec 15 '23 Option Exercise 14.82 6,409 94,973 52,941 Dec 18 04:11 PM Carruthers Wendy EVP, Human Resources Dec 15 '23 Sale 55.61 11,672 649,075 41,269 Dec 18 04:11 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Dec 06 '23 Sale 55.03 353 19,426 56,588 Dec 07 04:10 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Dec 03 '23 Option Exercise 0.00 649 0 57,237 Dec 04 05:42 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Nov 20 '23 Option Exercise 17.26 3,859 66,606 15,255 Nov 21 04:15 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Nov 20 '23 Sale 54.06 8,278 447,509 6,977 Nov 21 04:15 PM Carruthers Wendy EVP, Human Resources Nov 15 '23 Option Exercise 14.82 6,408 94,954 58,203 Nov 16 04:16 PM Carruthers Wendy EVP, Human Resources Nov 15 '23 Sale 54.17 11,671 632,269 46,532 Nov 16 04:16 PM Mahoney Michael F Chairman, President & CEO Nov 06 '23 Option Exercise 14.67 113,356 1,662,527 1,612,278 Nov 07 04:11 PM Mahoney Michael F Chairman, President & CEO Nov 06 '23 Sale 52.51 113,356 5,951,983 1,498,922 Nov 07 04:11 PM Carruthers Wendy EVP, Human Resources Oct 16 '23 Option Exercise 14.82 6,408 94,954 63,466 Oct 17 04:12 PM Carruthers Wendy EVP, Human Resources Oct 16 '23 Sale 49.79 11,671 581,063 51,795 Oct 17 04:12 PM Mahoney Michael F Chairman, President & CEO Oct 09 '23 Option Exercise 14.67 113,355 1,662,514 1,612,277 Oct 10 06:11 PM Mahoney Michael F Chairman, President & CEO Oct 09 '23 Sale 52.09 113,355 5,904,481 1,498,922 Oct 10 06:11 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Sep 20 '23 Sale 55.00 15,867 872,685 197,992 Sep 21 04:09 PM Carruthers Wendy EVP, Human Resources Sep 15 '23 Option Exercise 14.82 6,408 94,954 68,729 Sep 15 06:34 PM Carruthers Wendy EVP, Human Resources Sep 15 '23 Sale 53.95 11,671 629,694 57,058 Sep 15 06:34 PM Mahoney Michael F Chairman, President & CEO Sep 12 '23 Option Exercise 14.67 113,355 1,662,514 1,612,277 Sep 12 05:37 PM Mahoney Michael F Chairman, President & CEO Sep 12 '23 Sale 53.91 113,355 6,110,447 1,498,922 Sep 12 05:37 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Aug 29 '23 Sale 54.50 4,657 253,811 60,588 Aug 30 04:10 PM Mirviss Jeffrey B. EVP&Pres, Periph Intervent Aug 28 '23 Sale 53.14 13,971 742,419 65,245 Aug 30 04:10 PM Brown Vance R SVP, GC and Corp. Secretary Aug 25 '23 Sale 50.52 15,750 795,756 28,578 Aug 28 04:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite